Spleen weight and hematocrit in syngeneic recipient mice
| . | Control . | Hypertransfused . | ||
|---|---|---|---|---|
| Untreated . | RL73 F(ab′)2 . | Ter119 F(ab′)2 . | ||
| Spleen weight (g) | 0.05 ± 0.01 | 0.07 ± 0.01 | 0.12 ± 0.01 | 0.05 ± 0.01 |
| Hematocrit (%) | 62 ± 2 | 84 ± 1 | 70 ± 3 | 85 ± 3 |
| . | Control . | Hypertransfused . | ||
|---|---|---|---|---|
| Untreated . | RL73 F(ab′)2 . | Ter119 F(ab′)2 . | ||
| Spleen weight (g) | 0.05 ± 0.01 | 0.07 ± 0.01 | 0.12 ± 0.01 | 0.05 ± 0.01 |
| Hematocrit (%) | 62 ± 2 | 84 ± 1 | 70 ± 3 | 85 ± 3 |
Erythrocytes from peripheral blood were untreated or treated with RL73 F(ab′)2 or Ter119 F(ab′)2, then reinjected intravenously into mice. One day later, spleen weight and hematocrit were measured. Control, unmanipulated mice.